Starpharma Holdings Limited (OTCMKTS:SPHRY) Short Interest Update

Starpharma Holdings Limited (OTCMKTS:SPHRY) saw a large drop in short interest in November. As of November 15th, there was short interest totalling 2,600 shares, a drop of 42.2% from the October 31st total of 4,500 shares. Based on an average daily volume of 12,000 shares, the short-interest ratio is presently 0.2 days.

Starpharma Price Performance

OTCMKTS:SPHRY remained flat at $0.67 during mid-day trading on Friday. 90 shares of the company traded hands, compared to its average volume of 5,499. The company has a quick ratio of 4.58, a current ratio of 4.94 and a debt-to-equity ratio of 0.07. Starpharma has a 52-week low of $0.52 and a 52-week high of $1.33. The firm’s fifty day simple moving average is $0.68 and its 200-day simple moving average is $0.65.

Starpharma Company Profile

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.